Bias in high-throughput analysis of miRNAs and implications for biomarker studies

A certain degree of bias in high-throughput molecular technologies including microarrays and next-generation sequencing (NGS) is known. To quantify the actual impact of the biomarker discovery platform on miRNA profiles, we first performed a meta-analysis: raw data of 1539 microarrays and 705 NGS bl...

Full description

Saved in:
Bibliographic Details
Main Authors: Backes, Christina (Author) , Sedaghat-Hamedani, Farbod (Author) , Frese, Karen S. (Author) , Meder, Benjamin (Author)
Format: Article (Journal)
Language:English
Published: January 13, 2016
In: Analytical chemistry
Year: 2016, Volume: 88, Issue: 4, Pages: 2088-2095
ISSN:1520-6882
DOI:10.1021/acs.analchem.5b03376
Online Access:Verlag, Volltext: https://doi.org/10.1021/acs.analchem.5b03376
Verlag: https://pubs.acs.org/doi/10.1021/acs.analchem.5b03376
Get full text
Author Notes:Christina Backes, Farbod Sedaghat-Hamedani, Karen Frese, Martin Hart, Nicole Ludwig, Benjamin Meder, Eckart Meese, and Andreas Keller

MARC

LEADER 00000caa a2200000 c 4500
001 1681962012
003 DE-627
005 20230428191323.0
007 cr uuu---uuuuu
008 191115s2016 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.analchem.5b03376  |2 doi 
035 |a (DE-627)1681962012 
035 |a (DE-599)KXP1681962012 
035 |a (OCoLC)1341250512 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Backes, Christina  |e VerfasserIn  |0 (DE-588)1012608093  |0 (DE-627)704888971  |0 (DE-576)339810033  |4 aut 
245 1 0 |a Bias in high-throughput analysis of miRNAs and implications for biomarker studies  |c Christina Backes, Farbod Sedaghat-Hamedani, Karen Frese, Martin Hart, Nicole Ludwig, Benjamin Meder, Eckart Meese, and Andreas Keller 
264 1 |c January 13, 2016 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.11.2019 
520 |a A certain degree of bias in high-throughput molecular technologies including microarrays and next-generation sequencing (NGS) is known. To quantify the actual impact of the biomarker discovery platform on miRNA profiles, we first performed a meta-analysis: raw data of 1539 microarrays and 705 NGS blood-borne miRNomes were statistically evaluated, suggesting a substantial influence of the technology on biomarker profiles. We observed highly significant dependency of the miRNA nucleotide composition on the expression level. Higher expression in NGS was discovered for uracil-rich miRNAs (p = 7 × 10-37), while high expression in microarrays was found predominantly for guanine-rich miRNAs (p = 3 × 10-33). To verify the findings, 10 identical replicates of one individual were measured using NGS and microarrays (2525 miRNAs from miRBase version 21). Overall, we calculated a correlation coefficient of 0.414 for both technologies. Detailed analysis however revealed that the correlation was observed only for miRNAs in the early miRBase versions (<8). The majority of miRNAs (2013 from miRBase version 8 onward) was not correlated between microarray and NGS. Specifically, we observed 67 miRNAs with a median read count above 10 in NGS, while they were not detected in any of the 10 replicated array experiments. In contrast, 234 miRNAs were discovered in all 10 replicated array measurements but were not found in any of the NGS experiments of the same individual. While the first group had average guanine content of 22%, the latter group consisted of 41% of this nucleotide. Selected concordant and discordant miRNAs were tested in quantitative real-time-polymerase chain reaction (RT-qPCR) experiments again of the same individual, providing further evidence for the substantial bias depending on the base composition. As a consequence, biomarkers that have been discovered by specific high-throughout technologies have to be carefully considered. Especially for validation of the platform, the selection of reasonable candidates is essential. 
700 1 |a Sedaghat-Hamedani, Farbod  |d 1984-  |e VerfasserIn  |0 (DE-588)102545488X  |0 (DE-627)722303106  |0 (DE-576)370367138  |4 aut 
700 1 |a Frese, Karen S.  |e VerfasserIn  |0 (DE-588)1033468037  |0 (DE-627)741275961  |0 (DE-576)381062031  |4 aut 
700 1 |a Meder, Benjamin  |e VerfasserIn  |0 (DE-588)135821630  |0 (DE-627)571676316  |0 (DE-576)300664745  |4 aut 
773 0 8 |i Enthalten in  |t Analytical chemistry  |d Columbus, Ohio : American Chemical Society, 1947  |g 88(2016), 4, Seite 2088-2095  |h Online-Ressource  |w (DE-627)300896530  |w (DE-600)1483443-1  |w (DE-576)088704564  |x 1520-6882  |7 nnas  |a Bias in high-throughput analysis of miRNAs and implications for biomarker studies 
773 1 8 |g volume:88  |g year:2016  |g number:4  |g pages:2088-2095  |g extent:8  |a Bias in high-throughput analysis of miRNAs and implications for biomarker studies 
856 4 0 |u https://doi.org/10.1021/acs.analchem.5b03376  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://pubs.acs.org/doi/10.1021/acs.analchem.5b03376  |x Verlag 
951 |a AR 
992 |a 20191115 
993 |a Article 
994 |a 2016 
998 |g 135821630  |a Meder, Benjamin  |m 135821630:Meder, Benjamin  |d 910000  |d 910100  |e 910000PM135821630  |e 910100PM135821630  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1033468037  |a Frese, Karen S.  |m 1033468037:Frese, Karen S.  |d 910000  |d 910100  |e 910000PF1033468037  |e 910100PF1033468037  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 102545488X  |a Sedaghat-Hamedani, Farbod  |m 102545488X:Sedaghat-Hamedani, Farbod  |d 910000  |d 910100  |e 910000PS102545488X  |e 910100PS102545488X  |k 0/910000/  |k 1/910000/910100/  |p 2 
999 |a KXP-PPN1681962012  |e 3540571612 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"id":{"issn":["1520-6882"],"zdb":["1483443-1"],"eki":["300896530"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["19.1947 -"],"recId":"300896530","part":{"extent":"8","year":"2016","pages":"2088-2095","text":"88(2016), 4, Seite 2088-2095","issue":"4","volume":"88"},"note":["Gesehen am 27.08.2020","Ungezählte Beil.: News & features"],"disp":"Bias in high-throughput analysis of miRNAs and implications for biomarker studiesAnalytical chemistry","language":["eng"],"name":{"displayForm":["American Chemical Society"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"American Chemical Society","dateIssuedDisp":"1947-","dateIssuedKey":"1947","publisherPlace":"Columbus, Ohio"}],"title":[{"title":"Analytical chemistry","title_sort":"Analytical chemistry","subtitle":"the authoritative voice of the analytical community"}]}],"id":{"doi":["10.1021/acs.analchem.5b03376"],"eki":["1681962012"]},"name":{"displayForm":["Christina Backes, Farbod Sedaghat-Hamedani, Karen Frese, Martin Hart, Nicole Ludwig, Benjamin Meder, Eckart Meese, and Andreas Keller"]},"physDesc":[{"extent":"8 S."}],"origin":[{"dateIssuedDisp":"January 13, 2016","dateIssuedKey":"2016"}],"language":["eng"],"person":[{"family":"Backes","display":"Backes, Christina","roleDisplay":"VerfasserIn","role":"aut","given":"Christina"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Farbod","display":"Sedaghat-Hamedani, Farbod","family":"Sedaghat-Hamedani"},{"display":"Frese, Karen S.","role":"aut","roleDisplay":"VerfasserIn","given":"Karen S.","family":"Frese"},{"given":"Benjamin","roleDisplay":"VerfasserIn","role":"aut","display":"Meder, Benjamin","family":"Meder"}],"title":[{"title_sort":"Bias in high-throughput analysis of miRNAs and implications for biomarker studies","title":"Bias in high-throughput analysis of miRNAs and implications for biomarker studies"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1681962012","note":["Gesehen am 15.11.2019"]} 
SRT |a BACKESCHRIBIASINHIGH1320